VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
21 hedge funds and large institutions have $34.5M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 4 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
25% more capital invested
Capital invested by funds: $27.6M → $34.5M (+$6.83M)
5% more funds holding
Funds holding: 20 → 21 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$11.2M |
| 2 |
Millennium Management
New York
|
+$134K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$33.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$33.8K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$19.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$863K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$820K |
| 3 |
Renaissance Technologies
New York
|
-$49K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$40.6K |
| 5 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$2K |
VBIV Hedge Fund Activity: Q4 2016 in Review
21 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q4 2016, worth a combined $34.5M — up 25% from $27.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VBIV positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $11.2M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $863K sold.
- 21 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q4 2016, up from 20 in Q3 2016.
- Funds reported $34.5M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q4 2016, up 25% quarter-over-quarter.
- 5 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q4 2016 and 4 closed out, a net change of +1 holder.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q4 2016 was Perceptive Advisors, an estimated $11.2M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q4 2016 was Hudson Bay Capital Management, an estimated $863K sold.
Based on aggregated 13F filings for Q4 2016.